23 - 26 April, 2014
Hotel President Wilson, Geneva

Tuesday 23rd April 2013

3rd Annual LogiPharma Supply Chain Risk, Integrity & Security Summit

Have you minimised your Value Chain risk?

Take Action

Supply Chain Risk Conference AgendaSupply Chain Integrity HighlightsSupply Chain Security Conference PricingSupply Chain Conference

Are you prepared for the upcoming traceability and e-pedigree requirements and able to drive these benefits across the end to end supply chain beyond the regulatory obligations?

In Europe, EU inspectors now expect companies to be in compliance with requirements introduced by the Falsified Medicines Directive. Starting from 2013, both manufacturers and wholesalers must understand and action the new requirements along with manufacturers, importers and distributors of medicine.

Further afield, the California Board of Pharmacy are driving the traceability and e-pedigree agenda in North America with partial implementation expected to be complete by 2015.

With several key requirements already in place, the time for sitting on the fence has passed. The LogiPharma 3rd Annual LogiPharma Supply Chain Risk, Integrity & Security Summit will provide you with the expert insight, tools and strategy to drive compliance and improvements throughout the end-to-end supply chain organisation in risk, security and integrity.

It’s difficult to maintain supply chain integrity and continuously stay one step ahead of the criminals; however it’s even harder when you are a step behind. Discover who is stealing your profit, and ensure integrated approach to supply chain risk and integrity.

 

08:00 Registration and refreshments
Registration and refreshments
08:40 Chairperson's welcome and opening remarks
Ann Merchant, President, Schreiner MediPharm
Chairperson's welcome and opening remarks
speaker_default

Ann Merchant
President, Schreiner MediPharm

Ann Merchant is President of Schreiner MediPharm, a business unit of Schreiner Group based in Oberschleissheim near Munich in Germany. Schreiner MediPharm develops and produces innovative, multi-functional specialty labels with value-added benefits for the pharmaceutical industry. Ann is responsible for the sales organization, global strategy and further development of the business unit building o [read more]
08.50 Opening keynote: Drivers for, and industry response to, need for pharmaceutical supply chain security
Tim Valko, Executive Director Operations Risk Management, Amgen
Criminal threats to the pharmaceutical supply chain are increasing and becoming more sophisticated: counterfeiting, theft, Internet sales, and smuggling/illegal diversion of medicines. Governments are responding to these threats with new requirements around supply chain security including serialization, good distribution practices and incident alerts. Companies are building comprehensive supply chain security programs to support patient safety. Rx-360 is one industry organization that provides a forum for companies to collaborate in sharing and benchmarking different aspects of these programs.

This key note talk will summarize these drivers including reviews of recent actual incidents and will introduce attendees the benchmarking whitepapers and networking Rx-360 is producing to assist the supply chain in enhancing security.
  • Increasing criminal threats to the supply chain and growing regulatory attention to controls are driving manufacturers to develop comprehensive Supply Chain Security systems including
    • Recent trends in criminal attacks (counterfeits, thefts, Internet)
    • Analysis of recent actual incidents
    • Key regulatory drivers
    • Company approaches to protecting the supply chain
  • What does a fully integrated, global programme look like and how are companies learning from each other?
    • Introduction to the Rx-360 Supply Chain Security initiative – impacts on both developed and emerging markets
    • Completed benchmarking studies / whitepapers on: Management Systems, Cargo Theft, Market Monitoring, Audit/Assessments of Third Party Providers
    • Current projects: Unlawful Diversion, Management Notification, Serialization Discussion Group
    • Joint and shared supplier audits and other Rx-360 activities
speaker_default

Tim Valko
Executive Director Operations Risk Management, Amgen

Tim Valko has worked in Biopharmaceutical Supply Chain for over 19 years in positions in drug substance and drug product manufacturing, inspection and packaging, planning and inventory management, distribution and logistics, Import/export compliance and project management. Tim joined Amgen in 2007 as supply chain site head, at Amgen’s Fremont California manufacturing facility. C [read more]
09.20 Case study: Combining capacity and global risk management – diversifying centres of supply to manage and mitigate uncertainty worldwide
Hillel West, Executive Director, Operations and Supply Chain Strategy, Teva Pharmaceuticals
  • Balancing global supply and demand
  • Geopolitical risk considerations and the shift towards emerging markets as supply centres
    • Increasing scrutiny of API materials by regulators – what this means for network footprints and GMP
    • Supply surprises and realities on the ground
  • Fitting the strategy into an increasingly tender-based world
  • Ensuring preparedness for new markets and technologies
speaker_default

Hillel West
Executive Director, Operations and Supply Chain Strategy, Teva Pharmaceuticals

Hillel West is responsible for development of Operations and Supply Chain Strategy at Teva Pharmaceuticals - the world's largest supplier of generic pharmaceuticals. Teva's strategy includes the balancing of global optimisation with local accountability and a dynamic, entrepreneurial business culture. Hillel has 25 years Supply Chain experience in Pharmaceuticals and CPG, in various Supply Chain M [read more]
09.50 Case study: Securing the Sanofi supply chain
Frédéric Bourgeois, AVP, Global Quality Supply Chain, Sanofi
  • Where it all goes wrong – security & integrity done right, and how bad things can be when done wrong
  • Partnerships with regulatory bodies, customs and law enforcement – making the best use of your allies
  • Active surveillance measures to take
  • The utility of dedicated laboratory resources and infrastructure
  • A layered approach towards product protection and security
speaker_default

Frédéric Bourgeois
AVP, Global Quality Supply Chain, Sanofi

Frédéric Bourgeois is head of Global Quality Supply Chain for Sanofi Group. He is pharmacist. He has joined the Industrial Affairs of Sanofi in 1987 as plant manager, then, distribution platform manager in France and in the US, before to become Associate Vice President, in charge of leading and coordinating the Quality, Security and Traceability of Sanofi products [read more]
10.20 Innovation spotlight: Strengthening the supply chain by thinking out of the box
Markus Bauss, Senior Project Manager, Schreiner MediPharm
  • Combating the counterfeiters with smart and efficient security solutions
  • Multi-level security systems for tamper-evidence, authentication and track & trace
  • Innovative and unconventional approaches to adapt proven security technologies to your specific application
  • Case studies and practical examples to meet your anti-counterfeiting challenges
Markus Bauus

Markus Bauss
Senior Project Manager, Schreiner MediPharm

Markus Bauss is Senior Sales & Project Manager of Schreiner MediPharm, a business unit of Schreiner Group based in Oberschleissheim near Munich in Germany. Schreiner MediPharm develops and produces innovative, multi-functional specialty labels with value-added benefits for the pharmaceutical industry. Markus is in charge of global key account management and responsible for the mark [read more]
11.00 Tackling security and traceability from both a strategic and tactical level – Engaging with stakeholders and learnings from on-the-ground pilots
Jyrki Syvari, Corporate Director Supply Chain Integrity, Boehringer Ingelheim
  • Global serialisation updates and pilots underway
  • Aggregation – the hidden challenge
    • Manufacturing process challenges
    • Downstream distributor setbacks
  • 1D vs. 2D barcode implementations
  • The role of worldwide harmonisation and patient safety
speaker_default

Jyrki Syvari
Corporate Director Supply Chain Integrity, Boehringer Ingelheim

Jyrki Syväri, Pharmacist and Chemist, made his PhD Theses in Pharmaceutical Chemistry and his Diploma in Chemistry in Analytical Chemistry. He joined Schering AG in Berlin and headed there a R&D Laboratory for the development of parenteral drugs. He left Schering AG to join Boehringer Ingelheim (corporate headquarters), where he became a Project Manager in Operatio [read more]
11.45 Empowering an end-to-end serialization solution
Torben Vogt, Life Science Industry Expert, NNIT
  • Think beyond compliance – understand the full scope, direct and indirect of Pharmaceutical Serialisation and reap significant benefits for your company
  • Identifying the weakest link in your serialisation efforts, by thorough end-to-end planning of your initiative
  • Choose an existing experienced full service provider with deep pharma and serialization insight
speaker_default

Torben Vogt
Life Science Industry Expert, NNIT

Torben Vogt is a Life Science Industry Expert at NNIT, responsible for Business Development of Serialisation and Track & Trace. He has 25 years of experience from the industry and has been working at management level in number of functions, spanning from Finance, Planning, Logistics, Supply Chain, Sales & Marketing to IT. Prior to NNIT, he worked for 7 years at gene [read more]
13.15 Security and serialisation think-tank: Driving the benefits throughout the supply chain
David DeJean, Vice President, Systech International
  • Quantifying the benefits beyond regulatory compliance and counterfeiting – valuable applications in manufacturing, end to end visibility and optimisation and elsewhere
  • With European traceability regulations still in the distant future, and with supply chain benefits readily evident, is now the right time to implement your own solution?
  • Putting systems in place now to enable serialization data to be used for a competitive advantage
  • How do we overcome the implementation hurdles?
Structure: 5 minute presentation + 35 minute audience think tank and Q&A + 5 minute wrap-up
David M DeJean

David DeJean
Vice President, Systech International

Mr. DeJean, Vice President and veteran of Systech International for more than 25 years, is responsible for Systech’s Subject Matter Expertise Center, driven to support and educate customers and stakeholders on best practices for implementing a serialization program. As a member of the Executive Leadership Team, David brings a wealth of market knowledge, hands-on experience in se [read more]
14.00 Case study: Global product traceability in pharmaceutical production with SAP Track & Trace solutions
Stefan Hockenberger, Sales & Marketing Manager, Movilitas Consulting
Peer Laslo, Principal Consultant, SAP Deutschland
Case study: Global product traceability in pharmaceutical production with SAP Track & Trace solutions
speaker_default

Stefan Hockenberger
Sales & Marketing Manager, Movilitas Consulting

Stefan Hockenberger studied business administration in the “Berufsakademie Mannheim”, University of Cooperative Education. From 2002 to 2009 Stefan worked as Solution Sales Executive at SAP Germany AG & Co. KG and had the overall Pre-Sales responsibility for the “SAP Solutions for item Serialization (SAP AII/OER)& [read more]
speaker_default

Peer Laslo
Principal Consultant, SAP Deutschland

Peer Laslo studied Business Administration at “Hochschule Pforzheim” University for Business Administration, Technology and Arts,. Peer worked from 1997 to 2001 for KPMG as Consultant focusing on ERP implementation projects. For the next three years, Peer worked as freelancer for various ERP and Business Development Projects. In February 2005 Peer joined SAP B [read more]
14.30 Proactive risk management to prevent drug shortages: Strengthening a fragile supply chain
Thomas Zimmer, Corporate SVP, Environmental, Health, Safety and Sustainability, Boehringer Ingelheim
  • Conducting a root cause analysis: discovering where risks originate and the impacts on product supply globally
  • What regulatory bodies are doing in response – dealing with closer supply chain scrutiny
  • FDA and EU updates and expected regulation
  • Practical tools that can be immediately implemented to systematically assess and mitigate quality risk
  • The ethical dilemma: cost of goods vs. margin vs. standards Working together: proactive collaboration to solve drug shortages
speaker_default

Thomas Zimmer
Corporate SVP, Environmental, Health, Safety and Sustainability, Boehringer Ingelheim

SVP of the Corporate Division Quality & Environm. Health and SafetyHe studied pharmacy at the Johann Wolfgang Goethe University in Frankfurt/Main and made his PhD in Pharmaceutical Technology.Since 1981 Thomas Zimmer is with Boehringer Ingelheim where he had several positions in the Pharmaceutical Development and Pharmaceutical Manufacture and in the Area Management Operations (Ame [read more]
Afternoon Focus Workshops
17:00 Building a secure, global track and trace platform to protect patients and ensure compliance in today’s diverse regulatory and supply network environment
Shabbir Dahod, President and CEO, TraceLink
  • The patient safety, track and trace compliance and market access challenges confronting Life Sciences
  • Why big data, massive global networks, diverse track and trace regulations and changing technology standards are driving a Life Sciences transformation
  • The global cloud-based network information architecture required to meet this transformation
  • How leading companies are using cloud-based networks to protect product integrity and ensure compliance from ingredient to patient
  • The global track and trace environment and its business, operational and IT implications for Life Science companies
  • The hidden product, serialization and supply chain transaction data management challenges that put your company at risk 
  • The network information architecture required to meet emerging global compliance deadlines
  • Case study of how one Top-10 pharmaceutical company designed their core serialization and track and trace strategy to meet the global challenge and their learnings throughout deployment
Shabbir Dahod

Shabbir Dahod
President and CEO, TraceLink

Shabbir Dahod, President and CEO of TraceLink, has been a cutting-edge innovator focused on the intersection of technology, business and management to improve corporate performance for over 29 years. He led new collaboration and knowledge management initiatives at Microsoft before launching numerous startup companies including SupplyScape Corporation, the de-facto leader in software solutions to s [read more]
17.30 Californian E-Pedigree requirements: Taking a leadership role to drive national standards with international impacts
Virginia Herold, Executive Officer, California State Board of Pharmacy
  • History of the e-Pedigree movement
  • Determining the stakes at risk by delaying
  • Which technology solutions will maintain compliance – message/cloud/etc
  • Rule exemptions
  • Timelines: What must be done and by when?
  • Benefits to the recall process, patient health and manufacturer costs
  • Potential pre-emption by federal legislation / FDA action – what you need to know about the introduction of a national drug supply chain security bill into Congress
speaker_default

Virginia Herold
Executive Officer, California State Board of Pharmacy

Virginia Herold is the executive officer of the California State Board of Pharmacy, a position she has held since July 2006. Prior to this appointment, Ms. Herold served as assistant executive officer of the Board for 16 years.A graduate of the University of California, Ms. Herold holds Bachelor of Science and Master of Science degrees. Her education involved a blend of consumer protection, econom [read more]
18.00 Chairperson's summary & end of summit
Chairperson's summary & end of summit
18.15 LogiPharma networking drinks reception
LogiPharma networking drinks reception
19.30 LogiPharma Pre-Conference Networking Dinner
To be hosted by Camelot Management Consultants
This invitation-only dinner is solely for manufacturers attending Logipharma to network before the main conference begins. If you are interested in attending, please contact logipharma@wbr.co.uk Otherwise, you will receive a personal invitation from Camelot Management Consultants.

 

Theme2 Master Page Theme2 PageName:agenda.aspx EventInfo Id = 251146 Content Id = 251260 Content Title = focusdayagenda